ARTICLE | Clinical News
AAV-NTN: Phase IIb started
November 1, 2010 7:00 AM UTC
Ceregene began the double-blind, sham-controlled Phase IIb portion of a U.S. Phase I/IIb trial to evaluate CERE-120 administered via stereotactic injection directly into the substantia nigra and putam...